X0306 4/A 2020-10-01 2020-10-05 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 434 FAYETTEVILLE ST., SUITE 1400 RALEIGH NC 27601 false true false false SVP, Life Sciences Stock Option (Right to Buy) 4.71 2020-10-01 4 M false 1377.00 0.00 D 2028-08-06 Common Stock 1377.00 30003.00 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. 25% of this option shall vest and become exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. The original Form 4 filed on October 5, 2020, is being amended by this Form 4 amendment to correct the vesting schedule of this grant. The original Form 4 filed on October 5, 2020, is being amended by this Form 4 amendment to correct the number of derivative securities beneficially owned by the Reporting Person after the reported transaction. /s/ Allison Hoffman by Power of Attorney for David Linetsky 2021-09-10